Free Trial

Tectonic Therapeutic Q3 2023 Earnings Report

Tectonic Therapeutic logo
$47.44 +3.38 (+7.67%)
(As of 12/20/2024 05:16 PM ET)

Tectonic Therapeutic EPS Results

Actual EPS
-$0.44
Consensus EPS
-$0.23
Beat/Miss
Missed by -$0.21
One Year Ago EPS
N/A

Tectonic Therapeutic Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Tectonic Therapeutic Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

This Crypto Is Set to Explode in December (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

YES, I WANT THE #1 CRYPTO NOW

Tectonic Therapeutic Earnings Headlines

This Crypto Is Set to Explode in December
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…
Tectonic Therapeutic initiated with an Outperform at Raymond James
See More Tectonic Therapeutic Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Tectonic Therapeutic? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tectonic Therapeutic and other key companies, straight to your email.

About Tectonic Therapeutic

Avrobio, Inc. is a bio-technology company. It develops step-change cell and gene therapies for the treatment of cancer and rare disease. The company operates primarily in the United States and Canada. Avrobio, Inc. is based in MA, United States.

View Tectonic Therapeutic Profile

More Earnings Resources from MarketBeat

Upcoming Earnings